Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
Department of Pediatrics, Saint Louis Children's Hospital, Washington University School of Medicine , Saint Louis, Missouri.
Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G547-G558. doi: 10.1152/ajpgi.00362.2017. Epub 2018 Feb 1.
Biliary atresia (BA), a neonatal liver disease, is characterized by obstruction of extrahepatic bile ducts with subsequent cholestasis, inflammation, and progressive liver fibrosis. To gain insights into the pathophysiology of BA, we focused attention on GATA6, a transcription factor implicated in biliary development. Early in fetal development GATA6 expression is evident in cholangiocytes and hepatocytes, but by late gestation it is extinguished in hepatocytes. Utilizing a unique set of BA liver samples collected before and after successful portoenterostomy (PE), we found that GATA6 expression is markedly upregulated in hepatocytes of patients with BA compared with healthy and cholestatic disease controls. This upregulation is recapitulated in two murine models simulating bile duct obstruction and intrahepatic bile ductule expansion. GATA6 expression in BA livers correlates with two established negative prognostic indicators (age at PE, degree of intrahepatic bile ductule expansion) and decreases after normalization of serum bilirubin by PE. GATA6 expression in BA livers correlates with expression of known regulators of cholangiocyte differentiation ( JAGGED1, HNF1β, and HNF6). These same genes are upregulated after enforced expression of GATA6 in human hepatocyte cell models. In conclusion, GATA6 is a novel marker and a putative driver of hepatocyte-cholangiocyte metaplasia in BA, and its expression in hepatocytes is downregulated after successful PE. NEW & NOTEWORTHY A pathological hallmark in the liver of patients with biliary atresia is ductular reaction, an expansion of new bile ductules that are thought to arise from conversion of mature hepatocytes. Here, we show that transcription factor GATA6 is a marker and potential driver of hepatocyte ductal metaplasia in biliary atresia. Hepatocyte GATA6 expression is elevated in biliary atresia, correlates with bile duct expansion, and decreases after successful portoenterostomy.
先天性胆道闭锁(BA)是一种新生儿肝脏疾病,其特征为肝外胆管阻塞,随后出现胆汁淤积、炎症和进行性肝纤维化。为了深入了解 BA 的病理生理学,我们将注意力集中在 GATA6 上,它是一种参与胆管发育的转录因子。在胎儿发育早期,GATA6 在胆管细胞和肝细胞中表达,但在妊娠后期在肝细胞中消失。利用一组在成功进行肝门空肠吻合术(PE)前后收集的独特 BA 肝组织样本,我们发现与健康和胆汁淤积性疾病对照组相比,GATA6 在 BA 患者的肝细胞中表达明显上调。这种上调在模拟胆管阻塞和肝内胆管扩张的两种小鼠模型中得到了重现。BA 肝脏中的 GATA6 表达与两个已确立的负预后指标(PE 时的年龄、肝内胆管扩张程度)相关,并在 PE 使血清胆红素正常化后降低。BA 肝脏中的 GATA6 表达与已知胆管细胞分化调节剂(JAGGED1、HNF1β 和 HNF6)的表达相关。在人肝细胞模型中强制表达 GATA6 后,这些相同的基因也被上调。总之,GATA6 是 BA 中肝细胞-胆管细胞化生的新标志物和潜在驱动因子,其在肝细胞中的表达在成功进行 PE 后下调。新的和值得注意的是,在胆道闭锁患者的肝脏中,一个病理特征是小管反应,即新胆管的扩张,这些胆管被认为是由成熟肝细胞的转化而来的。在这里,我们表明转录因子 GATA6 是胆道闭锁中肝细胞胆管化生的标志物和潜在驱动因子。肝细胞 GATA6 表达在胆道闭锁中升高,与胆管扩张相关,并在成功进行肝门空肠吻合术后降低。